Telix Pharmaceuticals Limited

Pharmaceutical ManufacturingVictoria, Australia1001-5000 Employees

Telix Pharmaceuticals Limited operates in pharmaceutical manufacturing with a focus on theranostic radiopharmaceuticals, spanning therapeutic and diagnostic applications for oncology and rare diseases. The company develops and commercializes this portfolio from its headquarters in Melbourne, Australia, and maintains commercial operations in the United States, Europe (Belgium and Switzerland), and Japan. It employs between 1,001 and 5,000 people and is listed on the Australian Securities Exchange (ASX: TLX) and the Nasdaq Global Select Market (Nasdaq: TLX). Telix's radiopharmaceuticals target unmet medical needs in oncology and rare diseases, and the company has engaged in collaborations and industry activities in 2026, including a strategic theranostics partnership with United Imaging Group and participation in conferences such as SNMMI and ASCO. More information about the company is available on its website, telixpharma.com.

Sign up for free to view info

Email Format Employee directory